Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-528-1 | CAS number: 107-87-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral studies with rats and mice are available.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not specified
- Principles of method if other than guideline:
- The study guideline was equivlaent to the OECD 401 study.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Animals were given a single oral dose of the test article.
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 1 600 - < 3 200 mg/kg bw
- Conclusions:
- The LD50 of the study was given as 1600-3200 mg/kg.
- Executive summary:
Groups of rats were treated with methyl propyl ketone by oral gavage. The reported LD50 was 1600 -3200 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 600 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted in a GLP facility using OECD guidelines
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 436 (Acute Inhalation Toxicity: Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Details on inhalation exposure:
- The test item was contained in a glass syringe located on an infusion pump thus providing a constant supply of test item into the air stream. Immediately after the injection site, the air supply was ducted, via suitable tubing and a conical flask, through a water bath, maintained at approximately 50°C, to ensure complete vaporization. Compressed air was supplied by means of an oil free compressor and passed through a water trap and respiratory quality filters before it was introduced to the test item. The cylindrical exposure chamber had a volume of approximately 30 liters (dimensions: 28 cm diameter x 50 cm high). The concentration within the exposure chamber was controlled by adjusting the rate of the infusion pump. The extract from the exposure chamber passed through a ‘scrubber’ trap and was connected with a high efficiency filter to a metered exhaust system.
Homogeneity of the test atmosphere within the chamber was not specifically determined during this study. Chambers of the same design (ADG Developments Ltd, Hitchin, Herts, UK) have been fully validated and shown to produce evenly distributed atmospheres in the animals’ breathing zone with a wide variety of test items (Green J D et al, 1984). Prior to the start of the study, test item atmospheres were generated within the exposure chamber.
During this characterization period test item input rates were varied in an attempt to achieve the required atmospheric conditions.
On the day of exposure each rat was acclimatized (for approximately 2 hours) to a tapered polycarbonate restraining tube. During the exposure, each rat was individually held in a tapered, polycarbonate restraining tube fitted onto a single tier of the exposure chamber and sealed by means of a rubber ‘O’ ring. Only the nose of each animal was exposed to the test atmosphere. Following an appropriate equilibration period a single group of six rats (three males and three females) was exposed to an atmosphere of the test item for a period of four hours. A target concentration of 20 mg/L was used for the exposure. As the mean achieved concentration was 128% of target and no deaths occurred, no further levels were required. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 25.5 mg/l
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- 6 rats, (3 per sex per dose) were exposed to a single atmosphere of 25.5 mg/l of methyl n-propyl ketone for 4 hours, followed by a 14-day observation period.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 25.5 mg/L air (analytical)
- Exp. duration:
- 4 h
- Mortality:
- None
- Clinical signs:
- other: Common abnormalities noted during the study included increased respiratory rate, ataxia, hunched posture, pilo-erection and wet fur. There were occasional instances of prostration, an isolated occurrence of splayed gait was also noted. Animals recovered t
- Body weight:
- All animals exhibited body weight losses on the first day post-exposure. Reasonable bodyweight gains were noted for all animals during the remainder of the recovery period.
- Gross pathology:
- One male animal exhibited dark patches on the lungs at necropsy
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: OECD GHS
- Conclusions:
- No deaths occurred in a group of six rats exposed to a mean achieved atmosphere concentration of 25.5 mg/L for four hours. It was therefore considered that the acute inhalation median lethal concentration (4 hr LC50) of methyl propyl ketone, CAS# 107-87-9, in the RccHanTM : WIST strain rat, was greater than 25.5 mg/L .
- Executive summary:
A study was performed to assess the acute inhalation toxicity of the test item. The method used was designed to be compatible with that described in the OECD Guidelines for Testing of Chemicals (2009) No. 436 “Acute Inhalation Toxicity – Acute Toxic Class Method”. A group of six RccHan™ : WIST strain rats (three males and three females) was exposed to a vapor atmosphere. The animals were exposed for four hours using a nose only exposure system,followed by a fourteen day observation period. The mean achieved atmosphere concentration was 25.5 mg/l. Common abnormalities noted during the study included increased respiratory rate, ataxia, hunched posture, pilo-erection and wet fur. There were occasional instances of prostration, an isolated occurrence of splayed gait was also noted. Animals recovered to appear normal on Day 6 post-exposure. All animals exhibited body weight losses on the first day post-exposure. Reasonable bodyweight gains were noted for all animals during the remainder of the recovery period. One male animal exhibited dark patches on the lungs at necropsy. No deaths occurred in a group of six rats exposed to a mean achieved atmosphere concentration of 25.5 mg/L for four hours. It was therefore considered that the acute inhalation median lethal concentration (4 hr LC50) of methyl propyl ketone in the rat was greater than 25.5 mg/L.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 25 500 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
A study was performed to assess the acute inhalation toxicity of the test item. The method used was designed to be compatible with that described in the OECD Guidelines for Testing of Chemicals (2009) No. 436 “Acute Inhalation Toxicity – Acute Toxic Class Method”. A group of six RccHan™ : WIST strain rats (three males and three females) was exposed to a vapor atmosphere. The animals were exposed for four hours using a nose only exposure system, followed by a fourteen day observation period. The mean achieved atmosphere concentration was 25.5 mg/l. Common abnormalities noted during the study included increased respiratory rate, ataxia, hunched posture, pilo-erection and wet fur. There were occasional instances of prostration, an isolated occurrence of splayed gait was also noted. Animals recovered to appear normal on Day 6 post-exposure. All animals exhibited body weight losses on the first day post-exposure. Reasonable bodyweight gains were noted for all animals during the remainder of the recovery period. One male animal exhibited dark patches on the lungs at necropsy. No deaths occurred in a group of six rats exposed to a mean achieved atmosphere concentration of 25.5 mg/L for four hours. It was therefore considered that the acute inhalation median lethal concentration (4 hr LC50) of methyl propyl ketone in the rat was greater than 25.5 mg/L (Globally Harmonized Classification System –unclassified).
In a pair of acute oral toxicity studies, the LD50 was 1600 -3200 mg/kg for rats and 1600 mg/kg for mice. These studies were pre-GLP and not well documented, but were done in a state of the art facility to the standards of the time.
Acute dermal toxicity testing was not conducted as the test article is volatile.
Justification for selection of acute toxicity – dermal endpoint
Based on Annex VIII, this test was waived as the test article is volatile.
Justification for classification or non-classification
Acute oral toxicity testing supports an acute 4 classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.